- Home
- MDCX vs HBIO Comparison
MDCX vs HBIO Comparison
Compare MDCX & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDCX | HBIO |
|---|---|---|
| Founded | 2008 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.1M | 33.8M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | MDCX | HBIO |
|---|---|---|
| Price | $1.32 | $0.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $2.50 |
| AVG Volume (30 Days) | 279.5K | ★ 353.1K |
| Earning Date | 02-22-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $87,371,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.80 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.31 | $0.28 |
| 52 Week High | $8.94 | $1.98 |
Technical Indicators
Market Signals| Indicator | MDCX | HBIO |
|---|---|---|
| Relative Strength Index (RSI) | 28.54 | 38.25 |
| Support Level | $1.31 | $0.56 |
| Resistance Level | $1.48 | $0.62 |
| Average True Range (ATR) | 0.11 | 0.04 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 2.50 | 23.72 |
Price Performance
Historical ComparisonAbout MDCX Medicus Pharma Ltd.
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.